@entity1082 ) affects hundreds of millions of @entity1 worldwide and is associated with both benign and @entity5 in @entity1 and @entity1 . It is a double-stranded DNA virus with an icosahedral capsid. Forty HPV types are known to infect mucosal keratinocytes. If not cured by the immune system, the infection can lead to @entity3502 , @entity33 , or @entity5 . The most common oncogenic types are 16 and 18. The vaccine to prevent HPV and its associated morbidity and mortality has existed since 2006. Several variations protect against an increasing number of HPV types. The recommended vaccination age is before sexual exposure; administration of the vaccine to @entity1 has been controversial. This continuing medical education review evaluates the current HPV vaccines available to clinicians. Part I focuses on the debate over who should be vaccinated, at what age, and in which populations.

XXXX vaccine trials and tribulations: Clinical perspectives.

@entity1 :: ('9606', 'Species') :: ['women', 'children', 'people', 'men'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer', 'malignant neoplasms'] @entity33 :: ('MESH:D052016', 'Disease') :: ['mucosal dysplasia'] @entity3502 :: ('MESH:D003218', 'Disease') :: ['genital warts'] @entity1082 :: ('10566', 'Species') :: ['Human papillomavirus (HPV']
@entity1082 :: (10566,Species) :: ['Human papillomavirus']
